| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.86B | 12.28B | 13.27B | 17.29B | 16.13B | 12.76B |
| Gross Profit | 4.37B | 4.16B | 5.22B | 8.29B | 7.63B | 5.33B |
| EBITDA | 2.47B | 416.31M | 3.72B | 6.38B | 5.71B | 3.47B |
| Net Income | 153.77M | 172.77M | 1.56B | 4.21B | 3.96B | 2.00B |
Balance Sheet | ||||||
| Total Assets | 25.13B | 24.80B | 24.74B | 24.45B | 20.99B | 16.41B |
| Cash, Cash Equivalents and Short-Term Investments | 4.57B | 4.92B | 6.18B | 6.08B | 4.52B | 3.52B |
| Total Debt | 2.57B | 2.13B | 3.17B | 3.17B | 2.82B | 2.74B |
| Total Liabilities | 6.96B | 6.58B | 7.06B | 7.60B | 7.48B | 6.83B |
| Stockholders Equity | 17.77B | 17.83B | 17.45B | 16.73B | 13.44B | 9.52B |
Cash Flow | ||||||
| Free Cash Flow | 104.94M | 42.67M | -216.00M | 1.46B | 1.60B | 1.22B |
| Operating Cash Flow | 2.32B | 2.24B | 2.96B | 5.99B | 5.58B | 3.06B |
| Investing Cash Flow | -1.07B | 117.61M | -3.74B | -5.77B | -4.98B | -1.52B |
| Financing Cash Flow | -1.07B | -1.79B | -155.00M | -267.00M | -556.00M | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
| ― | €39.90B | 223.04 | 0.97% | 1.40% | -6.92% | -87.80% | |
72 Outperform | €11.35B | 80.63 | ― | ― | 15.69% | 49.60% | |
60 Neutral | €289.15M | 35.16 | 0.70% | 2.64% | 1.28% | -43.91% | |
54 Neutral | €51.71M | -13.70 | -51.98% | ― | -6.35% | 74.71% | |
54 Neutral | €379.11M | -51.58 | -3.24% | ― | 7.67% | 87.22% |